Clinical Trials Sponsored by Peking University Cancer Hospital & Institute

Total 18565 results

Peking University
Peking University Cancer Hospital & Institute

Not yet recruiting

Dexamethasone, Azacytidine,Pegaspargase and Tislelizumab for NK/T Cell Lymphoma

NK/T Cell Lymphoma

China
Peking University
Peking University Cancer Hospital & Institute

Suspended

Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Peking University Cancer Hospital & Institute
Peking University

Completed

DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma

Gastric Carcinoma

China
Peking University
Peking University Cancer Hospital & Institute

Recruiting

A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma

B Cell Non-Hodgkin's Lymphoma

China
Peking University Cancer Hospital & Institute
Peking University

Completed

Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using Mammography

Women With Breast Cancer

China
Peking University Cancer Hospital & Institute
Peking University Health Science Center

Recruiting

68Ga-ICAM-1pep PET/CT in Cancer Patients

Cancer

China
Peking University First Hospital
Peking University Cancer Hospital & Institute

Terminated

Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery

Delirium | Carcinoma, Non-Small-Cell Lung | Surgery--Complications | Dexamethasone | Flubiprofen Axetil

China
Peking University Cancer Hospital & Institute
Peking University Health Science Center

Recruiting

68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy

Cancer

China
Peking University People's Hospital
Peking University Cancer Hospital & Institute

Recruiting

Frontline of ASCT in High-risk DLBCL (Essential)

Diffuse Large B Cell Lymphoma

China
Peking University First Hospital
Peking University Cancer Hospital & Institute

Recruiting

Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients

Pain, Postoperative | Breast Neoplasms | Chronic Pain | Dexmedetomidine | Mastectomy | Prognosis | Nerve Block

China
Peking University Cancer Hospital & Institute

Not yet recruiting

First Human Trial of Targeting MDM2/MDMX PET Imaging

Nuclear Medicine | MDM2/MDMX Gene Mutation | Positron Emission Tomography Imaing
Peking University Cancer Hospital & Institute

Not yet recruiting

Neoadjuvant Fruquintinib Plus Tislelizumab Combined With mCapeOX Versus CapeOX for Mid-high pMMR/MSS Locally Advanced Rectal Cancer (PKUCH-R09)

Rectal Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression

Fallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma

China
Peking University Cancer Hospital & Institute

Recruiting

PD-L1 Specific [68Ga]-Nb-1 Nanobody Probe for PET Imaging in Solid Tumors

Solid Tumor

China
Peking University Cancer Hospital & Institute

Recruiting

Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer (ERSS-EGC)

Gastric Cancer | Esophageal Cancer | Risk Stratification | Precision Screening | Sequential Screening

China
Peking University Cancer Hospital & Institute

Not yet recruiting

Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma

Collecting Duct Carcinoma

China
Peking University Cancer Hospital & Institute

Recruiting

Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe

Cancer

China
Peking University Cancer Hospital & Institute

Not yet recruiting

KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma

HER2-positive Colorectal Cancer | HER2-positive Biliary Tract Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

The Value of MRI in Assessing the Status of Retroperitoneal Resection Margin in Colon Cancer

Colon Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy

Liver Metastasis Colon Cancer | Advanced Colorectal Carcinoma

China
Peking University Cancer Hospital & Institute

Recruiting

A Study of Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma

Urothelial Carcinoma

China
Peking University Cancer Hospital & Institute

Recruiting

A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer (NeoIpower)

Non-Small Cell Lung Cancer

China
Peking University Cancer Hospital & Institute

Not yet recruiting

cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC

HCC | Regorafenib | Transarterial Chemoembolization | Hepatic Arterial Infusion Chemotherapy
Peking University Cancer Hospital & Institute

Not yet recruiting

Evaluation System for the Efficacy of Immunologic Checkpoint Inhibitors in NSCLC

Non Small Cell Lung Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

PD-L1 Targeting Molecular Imaging of Solid Tumors

Gastrointestinal Tumors

China
Peking University Cancer Hospital & Institute

Not yet recruiting

Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma

Mucosal Melanoma | Neoadjuvant Treatment

China
Peking University Cancer Hospital & Institute

Recruiting

99mTc-MIRC208 SPECT/CT Imaging for HER2-Positive Cancer Patients

Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

The Molecular Imaging Research of F-18 Labeled DX600 PET Probe

Solid Tumor

China
Peking University Cancer Hospital & Institute

Recruiting

Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study

Mucosal Melanoma

China
Peking University Cancer Hospital & Institute

Recruiting

Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer

Rectal Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGC

Laparoscopic Surgery | Gastric Cancer | Gastrectomy | Lymphadenectomy

China
Peking University Cancer Hospital & Institute

Completed

Preliminary Study on Eye Features of Patients With Malignant Tumors

Cancer Patients | Feature Elongation

China
Peking University Cancer Hospital & Institute

Completed

The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma

HCC

China
Peking University Cancer Hospital & Institute

Active, not recruiting

RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy (TCM)

Cancer-related Problem/Condition

China
Peking University Cancer Hospital & Institute

Completed

Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer

Lung Cancer Metastatic

China
Peking University Cancer Hospital & Institute

Completed

Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal Carcinoma

Esophageal Cancer

China
Peking University Cancer Hospital & Institute

Completed

Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment

Rectal Cancer

China
Peking University Cancer Hospital & Institute

Unknown

Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI

Magnetic Resonance Imaging | Positron-Emission Tomography

China
Peking University Cancer Hospital & Institute

Unknown

TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC (OXRI)

Hepatocellular Carcinoma | Transarterial Chemoembolization
Peking University Cancer Hospital & Institute

Unknown

Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma

Melanoma
Peking University Cancer Hospital & Institute

Unknown

Drug Sensitivity Screening for Gastrointestinal Cancer

Gastrointestinal Cancer Metastatic

China
Peking University Cancer Hospital & Institute

Unknown

PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma

Melanoma

China
Peking University Cancer Hospital & Institute

Completed

RSYR for Fatigue Reduction in Cancer Survivors

Cancer-related Problem/Condition
Peking University Cancer Hospital & Institute

Unknown

Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal Gastrectomy

Gastric Cancer | GastroEsophageal Cancer
Peking University Cancer Hospital & Institute

Unknown

The Effect of Percutaneous Radiofrequency Ablation of Feeding Arterial for Hepatocellular Carcinoma

Liver Neoplasms

China
Peking University Cancer Hospital & Institute

Unknown

Endoscopic Ultrasound in Detailed T-staging of Upper GI Malignancies in Vitro

Gastrointestinal Neoplasms

China
Peking University Cancer Hospital & Institute

Unknown

Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma

Melanoma

China
Peking University Cancer Hospital & Institute

Unknown

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma

Lymphoma, Large B-Cell, Diffuse

China
Peking University Cancer Hospital & Institute

Unknown

A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST

Gastrointestinal Stromal Tumor

China

Clinical Trials Sponsored by Peking University Cancer Hospital & Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations